uniQure’s Huntington’s disease…
uniQure’s Huntington’s disease gene therapy has failed to significantly slow [...]
Novo’s ongoing efforts to…
Novo’s ongoing efforts to rejuvenate its pipeline have seen the [...]
Roche has slammed the brakes on an…
Roche has slammed the brakes on an obesity antibody after [...]
A phase 3 trial of Mirum…
A phase 3 trial of Mirum Pharmaceuticals’ chronic hepatitis delta [...]
The Biomedical Advanced Research…
The Biomedical Advanced Research and Development Authority (BARDA) has awarded [...]
Ahead of its upcoming merger with…
Ahead of its upcoming merger with Supernus, Indivior Pharmaceuticals has [...]
Novo has struck a 1.17 billion…
Novo has struck a 1.17 billion euro ($1.3 billion) deal [...]
ADARx Pharmaceuticals has overshot…
ADARx Pharmaceuticals has overshot its own IPO ambitions, as fellow [...]
A legal feud unfolding in New York…
A legal feud unfolding in New York is putting a [...]
Travere Therapeutics CEO Eric…
Travere Therapeutics CEO Eric Dube, Ph.D., is stepping down after [...]